神经退行性疾病的发展：2023 - 2024年发表于《脑科学》的高被引文章
Developments in Neurodegenerative Disorders: Highly Cited Articles Published in Brain Sciences in 2023-2024.
作者信息
de Carvalho Mamede
机构信息
Medicine ULisboa for Health Clinical Research and Innovation (MUHCRI), Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisbon, Portugal.
Department of Neurosciences and Mental Health, ULS de Santa Maria, 1649-028 Lisbon, Portugal.
出版信息
Brain Sci. 2025 Mar 27;15(4):345. doi: 10.3390/brainsci15040345.
Abstract
Neurodegenerative disorders, including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), pose a significant and growing health concern, particularly in developed countries [...].
摘要
神经退行性疾病，包括阿尔茨海默病（AD）、帕金森病（PD）和肌萎缩侧索硬化症（ALS），对健康构成了重大且日益严重的威胁，尤其是在发达国家[...]。
相似文献
1
Developments in Neurodegenerative Disorders: Highly Cited Articles Published in Brain Sciences in 2023-2024.神经退行性疾病的发展：2023 - 2024年发表于《脑科学》的高被引文章
Brain Sci. 2025 Mar 27;15(4):345. doi: 10.3390/brainsci15040345.
2
Shared genetic risk loci between Alzheimer's disease and related dementias, Parkinson's disease, and amyotrophic lateral sclerosis.阿尔茨海默病及相关痴呆、帕金森病和肌萎缩侧索硬化症之间的共享遗传风险基因座。
Alzheimers Res Ther. 2023 Jun 16;15(1):113. doi: 10.1186/s13195-023-01244-3.
3
Ten years preceding a diagnosis of neurodegenerative disease in Europe and Australia: medication use, health conditions, and biomarkers associated with Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.在欧洲和澳大利亚确诊神经退行性疾病前的十年：与阿尔茨海默病、帕金森病和肌萎缩侧索硬化症相关的药物使用、健康状况及生物标志物
EBioMedicine. 2025 Mar;113:105585. doi: 10.1016/j.ebiom.2025.105585. Epub 2025 Feb 5.
4
Hospital-treated infections in early- and mid-life and risk of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis: A nationwide nested case-control study in Sweden.早中年时期医院治疗感染与阿尔茨海默病、帕金森病和肌萎缩侧索硬化症风险的关系：瑞典全国性巢式病例对照研究。
PLoS Med. 2022 Sep 15;19(9):e1004092. doi: 10.1371/journal.pmed.1004092. eCollection 2022 Sep.
5
Cerebrospinal Fluid Inflammatory Cytokine Aberrations in Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.阿尔茨海默病、帕金森病和肌萎缩侧索硬化症中脑脊液炎症细胞因子的异常：系统评价和荟萃分析。
Front Immunol. 2018 Sep 19;9:2122. doi: 10.3389/fimmu.2018.02122. eCollection 2018.
6
Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.饮酒在阿尔茨海默病、帕金森病和肌萎缩侧索硬化症中的作用。
Int J Mol Sci. 2020 Mar 27;21(7):2316. doi: 10.3390/ijms21072316.
7
Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.抗氧化剂在治疗阿尔茨海默病、帕金森病和肌萎缩侧索硬化症中的生化及治疗作用。
Curr Drug Targets CNS Neurol Disord. 2003 Apr;2(2):95-107. doi: 10.2174/1568007033482959.
8
Alzheimer's, Parkinson's Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement.阿尔茨海默病、帕金森病和肌萎缩侧索硬化症基因表达模式的差异揭示了不同程度的 RNA 代谢参与。
Int J Mol Sci. 2020 Dec 14;21(24):9500. doi: 10.3390/ijms21249500.
9
Frequency of Parkinson's Disease Genes and Role of in Amyotrophic Lateral Sclerosis: An NGS Study.帕金森病基因的频率与在肌萎缩侧索硬化症中的作用：一项 NGS 研究。
Genes (Basel). 2022 Jul 22;13(8):1306. doi: 10.3390/genes13081306.
10
Pseudobulbar affect in neurodegenerative diseases: A systematic review and meta-analysis.神经退行性疾病中的假性球麻痹：一项系统评价和荟萃分析。
J Clin Neurosci. 2022 Jun;100:100-107. doi: 10.1016/j.jocn.2022.04.009. Epub 2022 Apr 15.
本文引用的文献
1
Lecanemab and Donanemab as Therapies for Alzheimer's Disease: An Illustrated Perspective on the Data.莱卡奈单抗和多奈单抗治疗阿尔茨海默病：数据的图解视角
eNeuro. 2024 Jul 1;11(7). doi: 10.1523/ENEURO.0319-23.2024. Print 2024 Jul.
2
Neuroinflammation and Neurodegenerative Diseases: How Much Do We Still Not Know?神经炎症与神经退行性疾病：我们仍有多少未知？
Brain Sci. 2023 Dec 23;14(1):19. doi: 10.3390/brainsci14010019.
3
Therapeutic targeting of ALS pathways: Refocusing an incomplete picture.治疗肌萎缩侧索硬化症相关通路：重新聚焦不完整的画面。
Ann Clin Transl Neurol. 2023 Nov;10(11):1948-1971. doi: 10.1002/acn3.51887. Epub 2023 Aug 28.
4
Neurological Insights into Sleep Disorders in Parkinson's Disease.帕金森病睡眠障碍的神经学见解
Brain Sci. 2023 Aug 14;13(8):1202. doi: 10.3390/brainsci13081202.
5
2023 Alzheimer's disease facts and figures.2023 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2023 Apr;19(4):1598-1695. doi: 10.1002/alz.13016. Epub 2023 Mar 14.
6
The Role of Glymphatic System in Alzheimer's and Parkinson's Disease Pathogenesis.类淋巴系统在阿尔茨海默病和帕金森病发病机制中的作用。
Biomedicines. 2022 Sep 13;10(9):2261. doi: 10.3390/biomedicines10092261.
7
Neuropathology of Alzheimer's Disease.阿尔茨海默病的神经病理学。
Neurotherapeutics. 2022 Jan;19(1):173-185. doi: 10.1007/s13311-021-01146-y. Epub 2021 Nov 2.
8
Parkinsonism and cerebrovascular disease.帕金森病与脑血管病。
J Neurol Sci. 2022 Feb 15;433:120011. doi: 10.1016/j.jns.2021.120011. Epub 2021 Oct 6.
9
Hypothalamic α-synuclein and its relation to autonomic symptoms and neuroendocrine abnormalities in Parkinson disease.下丘脑α-突触核蛋白与帕金森病自主症状和神经内分泌异常的关系。
Handb Clin Neurol. 2021;182:223-233. doi: 10.1016/B978-0-12-819973-2.00015-0.
10
Hypothalamus and weight loss in amyotrophic lateral sclerosis.下丘脑与肌萎缩侧索硬化症的体重减轻。
Handb Clin Neurol. 2021;180:327-338. doi: 10.1016/B978-0-12-820107-7.00020-3.
Zotero 插件